FDA Approved: CINVANTI — Original Application (Heron Therapeutics, Inc.)

View source ↗

Summary

The FDA approved CINVANTI (aprepitant) under an original NDA from Heron Therapeutics for preventing chemotherapy-induced nausea and vomiting in patients receivi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• CINVANTI (aprepitant)

Snippet

ORIG AP for CINVANTI (APREPITANT)